Molecular basis of pituitary dysfunction in mouse and human

Mammalian Genome

Volumn 12, Issue 7, 2001, Pages 485-494

  Cushman, Lisa J ^a   Camper, Sally A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOMEODOMAIN PROTEIN; TRANSCRIPTION FACTOR;

GENE DELETION; GENE EXPRESSION REGULATION; GENE MUTATION; HORMONE DEFICIENCY; HUMAN; HYPOPHYSIS; HYPOPHYSIS ADENOMA; HYPOPHYSIS DISEASE; MOUSE; NONHUMAN; ONTOGENY; ORGANOGENESIS; REVIEW;

ADENOMA; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MICE; MUTATION; PITUITARY GLAND; PITUITARY NEOPLASMS; TRANSCRIPTION FACTORS;

RODENTIA;

EID: 0034971555     PISSN: 09388990     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003350040002     Document Type: Review

References (129)

1. Transient dwarfism and hypogonadism in mice lacking Otxl reveal prepubescent stage-specific control of pituitary levels of GH, FSH and LH
2. A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans
3. Adrenocorticotropin deficiency in combined pituitary hormone deficiency patients homozygous for a novel PROP1 deletion
4. Pituitary-directed leukemia inhibitory factor transgene forms Rathke's cleft cysts and impairs adult pituitary function
5. The Ames dwarf gene is required for Pit-1 gene activation
6. Constitutively signaling G-protein-coupled receptors and human disease
7. The pathology of pituitary tumors
8. The cytogenesis and pathogenesis of pituitary adenomas
9. Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice
10. A new mutation in the Pit-1 gene, discovered by the neonatal congenital hypothyroidism (CH) screening program
11. Genetic models in the study of anterior pituitary hormones
12. Treatment of hyperthyroidism due to inappropriate secretion of thyrotropin with the somatostatin analog SMS 201-995
13. Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insufficiency
14. Haploinsufficiency of steroidogenic factor-1 in mice disrupts adrenal development leading to an impaired stress response
15. Defective interaction of a mutant Pit-1, K216E, with CBP inhibits human prolactin gene expression
16. Central hypothyroidism reveals compound heterozygous mutations in the Pit-1 gene
17. Steroidogenic factor-1 (SF-1) and the regulation of expression of luteinizing hormone and follicle stimulating hormone β-subunits in the sheep anterior pituitary in vivo
18. Spectrum of pituitary disease in multiple endocrine neoplasia type 1 (MEN1): Clinical, biochemical, and radiological features of pituitary disease in a large MEN 1 kindred
19. Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series
20. Genealogy of the anterior pituitary gland: Tracing a family tree
21. The Pit-1 transcription factor gene is a candidate for the Snell dwarf mutation
22. Identification of a novel genetic locus for familial cardiac myxomas and Carney complex
23. Mutations in the protein kinase A R1 α regulatory subunit cause cardiac myxomas and Carney complex
24. Positional cloning of the gene for multiple endocrine neoplasia-type 1
25. Signal transduction defects in growth hormone insensitivity
26. The PROP1 2-base pair deletion is a common cause of combined pituitary hormone deficiency
27. Signaling mechanisms in pituitary morphogenesis and cell fate determination
28. Reciprocal interactions of Pit1 and GATA2 mediate signaling gradient-induced determination of pituitary cell types
29. The molecular basis for developmental disorders of the pituitary gland in man
30. Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse
31. Novel mutations of HESX1 associated with septo-optic dysplasia in man
32. LIM domain proteins
33. Embryology of the pituitary gland
34. Fetal development and regulation of pituitary cell types
35. Human Prop-1: Cloning, mapping, genomic structure
36. A binding site for steroidogenic factor-1 is part of a complex enhancer that mediates expression of the murine gonadotropin-releasing hormone receptor gene
37. Modern imaging of the pituitary
38. Kip1 -deficient mice
39. Phenotypic variability in familial combined pituitary hormone deficiency caused by a PROP1 gene mutation resulting in the substitution of Arg → Cys at Codon 120 (R120C)*
40. Compound heterozygous deletion of the PROP-1 gene in children with combined pituitary hormone deficiency
41. Rarity of Pit-1 involvement in children from Russia with combined pituitary hormone deficiency
42. MR Imaging of the pituitary gland in children and young adults with congenital combined pituitary hormone deficiency associated with PROP I mutations
43. The Ames dwarf gene, df is required early in pituitary ontogeny for the extinction of Rpx transcription and initiation of lineage specific cell proliferation
44. Anterior pituitary cells defective in the cell autonomous factor, df undergo cell lineage specification but not expansion
45. Dosage requirement of Pitx2 for development of multiple organs
46. Stimulation of luteinizing hormone beta gene promoter activity by the orphan nuclear receptor, steroidogenic factor-1
47. Expression of human growth hormone-releasing factor in transgenic mice results in increased somatic growth
48. Identification of alternatively spliced messenger ribonucleic acid encoding truncated growth hormone-releasing hormone receptor in human pituitary adenomas
49. New pituitary oncogenes
50. Transgenic mice that develop pituitary tumors. A model for Cushing's disease
51. Rpx: A novel anterior-restricted homeobox gene progressively activated in the prechordal plate, anterior neural plate, and Rathke's pouch of the mouse embryo
52. The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis
53. A novel E250X mutation of the PIT1 gene in a patient with combined pituitary hormone deficiency
54. A naturally occurring steroidogenic factor-1 mutation exhibits differential binding and activation of target genes
55. Effects of an Rb mutation in the mouse
56. In situ hybridization analysis of anterior pituitary hormone gene expression during fetal mouse development
57. ras mutations in human pituitary tumors
58. Targeted disruption of the pituitary glycoprotein hormone alpha-subunit produces hypogonadal and hypothyroid mice
59. A steroidogenic factor-1 binding site is required for activity of the luteinizing hormone β subunit promoter in gonadotropes of transgenic mice
60. Pax6 is essential for establishing ventral-dorsal cell boundaries in pituitary gland development
61. Mutations of the gene encoding the protein kinase A type 1-α regulatory subunit in patients with Carney complex
62. Mouse Pitx2 deficiency leads to anomalies of the ventral body wall, heart, extra- and periocular mesoderm and right pulmonary isomerism
63. The hereditary multiple pituitary hormone deficiency (MPHD) dwarfs on the island of Krk have a defect in the transcription factor PROP-1
64. The "little people" of the island of Krk-revisited: Etiology of hypopituitarism revealed
65. Simian virus 40 T antigen-induced gonadotroph adenomas: A model for human null cell adenomas
66. Hindlimb patterning and mandible development require the Ptx1 gene
67. Luteinizing hormone deficiency and female infertility in mice lacking the transcription factor NGF1-A (Egr-1)
68. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene Pit-1
69. Pitx2 regulates lung asymmetry, cardiac positioning and pituitary and tooth morphogenesis
70. Surgical pathology of the pituitary gland
71. Function of Rieger syndrome gene in left-right asymmetry and craniofacial development
72. A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation
73. Targeted pituitary tumorigenesis using the human thyrotropin beta-subunit chain promoter in transgenic mice
74. Targeting of transforming growth factor-alpha expression to pituitary lactotrophs in transgenic mice results in selective lactotroph proliferation and adenomas
75. Pathogenesis of pituitary tumors
76. Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency
77. Steroidogenic factor-1 interacts with a gonadotrope-specific element within the first exon of the human gonadotropin-releasing hormone receptor gene to mediate gonadotrope-specific expression
78. Mutations in the PIT-1 gene in children with combined pituitary hormone deficiency
79. Combined pituitary hormone deficiency caused by a novel mutation of a highly conserved residue (F88S) in the homeodomain of PROP-1
80. Transcriptional control of the development and function of the hypothalamic-pituitary axis
81. Heritable disorders of pituitary development
82. Isolation and characterization of a pituitary tumor-transforming gene (PTTG)
83. Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: Evidence for a chromosome 13 tumor suppressor gene other than RB
84. A new mutation of the gene encoding the transcription factor Pit-1 is responsible for combined pituitary hormone deficiency
85. Pro239Ser: A novel recessive mutation of the Pit-1 gene in seven Middle Eastern children with growth hormone, prolactin, and thyrotropin deficiency
86. Impaired adrenocorticotropin-adrenal axis in combined pituitary hormone deficiency caused by a two-base pair deletion (301-302delAG) in the prophet of Pit-1 gene
87. Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia
88. Molecular characterization of the Men1 tumor suppressor gene in sporadic pituitary tumors
89. The molecular genetics of growth hormone deficiency
90. A mutation in the POU-homeodomain of Pit-1 responsible for combined pituitary hormone deficiency
91. Molecular involvement of the Pit-1 gene in pituitary cell commitment
92. Transcriptional mechanisms in anterior pituitary cell differentiation
93. The occurrence of dural invasion in pituitary adenomas
94. Specification of pituitary cell lineages by the LIM homeobox gene Lhx3
95. Multistep control of pituitary organogenesis
96. Prolactinomas express human heparin-binding secretory transforming transforming gene product: Marker of tumor invasiveness
97. Expression of the pituitary transcription factor Ptx-1, but not that of the trans-activating factor Prop-1, is reduced in human corticotroph adenomas and is associated with decreased alpha-subunit secretion
98. Differential activation of pituitary hormone genes by human Lhx3 isoforms with distinct DNA binding properties
99. Molecular analysis of LHX3 and PROP-1 in pituitary hormone deficiency patients with posterior pituitary ectopia
100. Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism
101. G protein oncogenes in pituitary tumors
102. Genetic bases of estrogen-induced pituitary growth in an intercross between ACI and Copenhagen rat strains: Dominant Mendelian inheritance of the ACI phenotype
103. Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2
104. Cytogenetic and microsatellite alterations in tumors from patients with the syndrome of myxomas, spotty skin pigmentation, and endocrine overactivity (Carney complex)
105. Role of bicoid-related homeodomain factor Pitx1 in specifying hindlimb morphogenesis and pituitary development
106. Gonadotropin secretion, synthesis, and gene expression in human growth hormone transgenic mice and in Ames dwarf mice
107. Cretinism with combined hormone deficiency caused by a mutation in the Pit-1 gene
108. Multiple pituitary and ovarian defects in Krox-24 (NGF1-A, Egr1)-targeted mice
109. The endocrine system
110. An early haematopoietic defect in mice lacking the transcription factor GATA-2
111. s and adenylate cyclase activity in human GH-secreting pituitary adenomas
112. Two hot spots in the PROP1 gene of patients with multiple pituitary hormone deficiency
113. A novel mutation Arg99Gln in the hot spot region of Prop-1 gene causing familial combined pituitary hormone deficiency
114. Prevalence of severe growth hormone deficiency
115. Nonsense mutation in the human growth hormone-releasing hormone receptor gene causes growth failure analogous to the little (lit) mouse
116. How many homeobox genes does it take to make a pituitary gland?
117. Quantitative trait loci for estrogen-dependent pituitary tumor growth in the rat
118. Different functions of QTL for estrogen-dependent tumor growth of the rat pituitary
119. Transsphenoidal microsurgical removal of 250 pituitary adenomas
120. Cell lines of the pituitary gonadotrope lineage derived by targeted oncogenesis in transgenic mice
121. Abundance and state of phosphorylation of the retinoblastoma gene product in human pituitary tumors
122. INK4a gene product in human pituitary tumours
123. Mutations in PROP1 cause familial combined pituitary hormone deficiency
124. Pituitary-directed leukemia inhibitory factor transgene causes cushing's syndrome: Neuro-immune-endocrine modulation of pituitary development
125. Pituitary tumor transforming gene expression in human pituitary adenomas
126. Structure, expression and function of human pituitary tumor transforming gene (PTTG)
127. Steroidogenic factor 1 (SF-1) is essential for pituitary gonadotrope function
128. Indentification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis